Back to Bills
Introduced

HB6301: Cancer Drug Parity Act of 2023

: Glenn Grothman (R-US) : May 25, 2026 Updated: Nov 8, 2023
Health
Bill ProgressIntroduced
  1. 1Introduced (current step)
  2. 2Passed One Chamber
  3. 3Passed Both Chambers
  4. 4Became Law

Here is how to read this bill

  1. Start with the summary

    It says what the bill does in plain language. The official text is one tab over.

  2. Check where it is

    The status badge says how far it has gotten. The History tab lists every step.

  3. Follow it

    We will email you when it moves. You need a free account.

  4. Tell someone who votes on it

    Email or call the sponsor, or find your own representatives, from the actions panel.

Bill information

Summary

To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.

Plain-language summary

The Cancer Drug Parity Act of 2023 would require group health plans and health insurance to charge patients the same cost-sharing amounts for cancer drugs taken as pills at home as for cancer drugs given by doctors in clinics. Cost-sharing means the money patients must pay out-of-pocket, such as copays or deductibles. Currently, insurance plans often charge patients more for oral cancer drugs than for injectable ones. The bill amends the Employee Retirement Income Security Act, which governs employer health plans. The bill has been introduced in Congress but has not yet advanced through the process.

AI-generated summary

What can I do?

It's early in the process — messages to the sponsor and your representatives carry the most weight right now.

Contact Your Representatives

Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.

Find Your Representatives

Share This Bill

Sharing helps others in your district get informed and involved.

Message style

HB6301: Cancer Drug Parity Act of 2023

Upcoming hearings & events

Loading upcoming hearings